Invest Ophthalmol Vis Sci
Invest Ophthalmol Vis SciJuly 2025Observational Study

Natural Course and Risk Factors of Glaucoma Development in the Untreated Fellow Eye in Unilateral Normal-Tension Glaucoma.

IOP & Medical TherapyDisease Progression

Summary

In this 8-year cohort, we observed NTG development in the untreated fellow eyes in 24.7% of the patients with unilateral NTG.

Abstract

PURPOSE

To test whether the level of intraocular pressure (IOP) significantly affects the development of glaucoma in the untreated fellow eye of patients with unilateral normal-tension glaucoma (NTG).

METHODS

Long-term observational study on consecutive patients newly diagnosed with unilateral NTG and followed up for >5 years with more than five IOP measurements. We investigated the factors associated with NTG development in the untreated fellow eye, including the longitudinal IOP profile.

RESULTS

A total of 194 patients with a baseline age of 50.5 ± 12.1 years were followed up for 8.4 ± 1.6 years. NTG development in the untreated fellow eye occurred in 48 patients (24.7%), with a mean interval of 5.2 ± 2.1 years. Patients with fellow eye NTG development had significantly higher baseline untreated IOP in both eyes and higher follow-up IOPs in the fellow eye compared to those who did not (all P < 0.05). Kaplan-Meier survival analysis and multivariate Cox regression analysis revealed that an average follow-up IOP ≥14 mm Hg in the fellow eye was associated with a significantly increased risk of glaucoma development compared to those with IOP <14 mm Hg (hazard ratio, 3.626; 95% confidence interval, 1.519-8.654; P = 0.004), particularly for the eyes with baseline IOP ≥14 mm Hg.

CONCLUSIONS

In this 8-year cohort, we observed NTG development in the untreated fellow eyes in 24.7% of the patients with unilateral NTG. The untreated average follow-up IOP was significantly associated with NTG development, with an average IOP ≥14 mm Hg exhibiting a threefold increased risk.

In the Knowledge Library

Discussion

Comments and discussion will appear here in a future update.